Mounjaro Suitability: Who Qualifies for Treatment?

  • Comprehensive medical history evaluation including current health conditions and previous treatments
  • Detailed medication review to identify potential interactions or contraindications
  • Assessment of individual weight management goals and realistic treatment expectations
  • Clinical determination of risk-benefit profile based on personal health circumstances
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

Understanding Mounjaro Treatment Suitability Criteria

Who May Be Considered for Mounjaro Treatment

Mounjaro suitability assessment begins with understanding that this prescription-only medicine may be considered for some adults following comprehensive clinical evaluation. UK-licensed prescribers evaluate each individual case based on multiple health factors, ensuring treatment appropriateness before prescribing decisions are made. The assessment process considers overall health status, weight management history, and individual circumstances that influence treatment suitability.

Adults seeking Mounjaro treatment must demonstrate commitment to lifestyle changes including reduced-calorie diet and increased physical activity, as this weekly injectable medicine is designed to support these essential modifications rather than replace them. Prescribers assess whether patients understand the comprehensive approach required for effective weight management, including ongoing dietary changes and regular physical activity.

Individual health circumstances play a crucial role in determining suitability, with prescribers evaluating factors such as previous weight management attempts, current health status, and realistic treatment goals. The assessment ensures that patients have appropriate expectations about what Mounjaro can achieve when combined with lifestyle modifications.

Medical Assessment Criteria and Evaluation Process

The clinical assessment process involves detailed evaluation of medical history, current health conditions, and potential contraindications that might affect treatment suitability. UK prescribers review comprehensive health information to identify any factors that could influence the safety or appropriateness of Mounjaro treatment for individual patients.

Current medications undergo thorough review during the assessment process, as certain treatments may interact with Mounjaro or indicate underlying conditions that affect suitability. Prescribers evaluate the complete medication profile to ensure safe prescribing practices and identify any adjustments that might be necessary.

The assessment includes evaluation of previous weight management experiences, understanding what approaches have been tried previously and their outcomes. This historical perspective helps prescribers determine whether Mounjaro represents an appropriate next step in comprehensive weight management planning.

Mental health considerations form part of the holistic assessment, ensuring that patients have realistic expectations and appropriate support systems in place for successful weight management. Prescribers evaluate whether individuals are prepared for the lifestyle changes that accompany effective treatment.

Contraindications and Exclusion Criteria

Certain medical conditions and circumstances may make Mounjaro unsuitable for some individuals, with prescribers carefully evaluating contraindications during the assessment process. Pregnancy and breastfeeding represent absolute contraindications, as this medicine is not recommended during these periods due to potential risks to mother and baby.

Specific medical conditions may affect treatment suitability, requiring prescribers to weigh individual risk-benefit profiles before making prescribing decisions. The assessment process identifies any conditions that might increase treatment risks or reduce potential benefits for individual patients.

Age considerations factor into suitability assessment, as Mounjaro is specifically indicated for adult patients who meet clinical criteria. Prescribers ensure that treatment candidates fall within appropriate age ranges and demonstrate mature understanding of treatment requirements.

Previous adverse reactions to similar medications may influence suitability decisions, with prescribers reviewing treatment history to identify potential sensitivities or contraindications. This comprehensive review ensures that patients with previous problematic responses to weight management medications receive appropriate clinical consideration.

Individual Assessment and Prescriber Decision-Making

Each suitability assessment is conducted on an individual basis, recognizing that weight management needs and health circumstances vary significantly between patients. UK-licensed prescribers use clinical judgment to evaluate how Mounjaro might fit into comprehensive treatment plans tailored to individual requirements.

The decision-making process balances potential benefits against individual risk factors, ensuring that treatment recommendations align with patient safety priorities and realistic outcome expectations. Prescribers consider multiple factors simultaneously when determining whether Mounjaro represents appropriate treatment for specific individuals.

Patient readiness for lifestyle changes undergoes evaluation during the assessment process, as successful treatment requires ongoing commitment to dietary modifications and increased physical activity. Prescribers assess whether individuals demonstrate understanding and motivation for comprehensive weight management approaches.

Follow-up planning forms part of the initial suitability assessment, with prescribers considering how ongoing monitoring and support will be provided throughout treatment. This forward-looking approach ensures that patients receive appropriate clinical oversight and support for successful weight management outcomes.

The final prescribing decision represents clinical judgment based on comprehensive evaluation of all relevant factors, ensuring that Mounjaro is only prescribed where clinically appropriate and likely to contribute positively to individual weight management goals. Prescribers maintain ultimate responsibility for treatment suitability decisions based on professional medical assessment.

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions